Page 64 - Hikma - Oncology booklet
P. 64
Dosage adjustments recommendations
Click to edit Master title style
1
Withhold :
Angina, MI, ischemia, arrhythmia, or HF.
Hyperammonemic encephalopathy.
Confusion, disorientation, ataxia
Grade 3 or 4 diarrhea & mucositis.
Grade 2 or 3 hand-foot syndrome.
Grade 4 myelosuppression.
2 Administration at a dose
Grade 1 diarrhea, mucositis, hand-foot
syndrome and myelosuppression.
Side effects
Hyperammonemic encephalopathy
Neurologic toxicity Cardiotoxicity
Mucositis Diarrhea
Myelosuppression Bronchospasm
Palmar-plantar erythrodysesthesia (hand-foot syndrome)
18/01/2020 3
63